2007
DOI: 10.1016/j.jaad.2006.03.019
|View full text |Cite
|
Sign up to set email alerts
|

Mycosis fungoides involving the nasal mucosa

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
1
0
1

Year Published

2009
2009
2024
2024

Publication Types

Select...
4
2

Relationship

0
6

Authors

Journals

citations
Cited by 7 publications
(2 citation statements)
references
References 6 publications
0
1
0
1
Order By: Relevance
“…The skin processes were mycosis fungoides (case 8) and primary cutaneous anaplastic large cell lymphoma (case 9), with mucosal disease presenting in the nasal cavity and tongue, respectively. Occasional cases of mycosis fungoides [26][27][28] and lymphomatoid papulosis 16,21,[29][30][31][32] have been reported to involve both cutaneous and mucosal sites, particularly the oral cavity. Some cases of lymphomatoid papulosis with oral involvement also showed genital involvement.…”
Section: Discussionmentioning
confidence: 99%
“…The skin processes were mycosis fungoides (case 8) and primary cutaneous anaplastic large cell lymphoma (case 9), with mucosal disease presenting in the nasal cavity and tongue, respectively. Occasional cases of mycosis fungoides [26][27][28] and lymphomatoid papulosis 16,21,[29][30][31][32] have been reported to involve both cutaneous and mucosal sites, particularly the oral cavity. Some cases of lymphomatoid papulosis with oral involvement also showed genital involvement.…”
Section: Discussionmentioning
confidence: 99%
“…Aufgrund ihrer lokalen Morphe lassen sie sich klinisch meistens nicht differenzieren, sondern sind nur im Zusammenhang mit anderen, typischen Hautveränderungen im Bereich des Integumentes einzuordnen. Probebiopsien machen eine Zuordnung möglich, was insbesondere bei den kutanen Lymphomerkrankungen zur Abgrenzung einer Schleimhautbeteiligung und Einleitung therapeutischer Konsequenzen nö-tig sein kann [10]. Wie bei den vorgenannten Erkrankungen ist eine Therapie je nach Beschwerden und Ausdehnung der Erkrankung erforderlich und umfasst im Wesentlichen topische Kortikosteroide.…”
Section: Andere Papulosquamöse Erkrankungenunclassified